Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 90 Results

May 6, 2021

Surrozen Strengthens Board of Directors with Appointments of Mace Rothenberg, M.D.,and Christopher Chai

April 15, 2021

Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration

March 11, 2021

Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho,Ph.D.

February 2, 2021

Surrozen Expands Board of Directors with Appointment of Shao-Lee Lin, M.D.,Ph.D.

November 12, 2020

Surrozen to Present at the Stifel 2020 Virtual Healthcare Conference

October 29, 2020

Surrozen Appoints Charles Williams as Chief Financial Officer

October 15, 2020

Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody,for the Treatment of Severe Alcoholic Hepatitis

September 25, 2020

Surrozen Expands Board of Directors with Appointment of David J. Woodhouse,Ph.D.

September 16, 2020

Surrozen to Present at Morgan Stanley 18th Annual Global Healthcare Conference

August 19, 2020

Surrozen Announces Publication of Second Antibody Platform Technology in Scientific Reports

«...5 6 789 »

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

Privacy Policy
FCOI Policy
Accessibility

Scroll to Top